SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-003512
Filing Date
2024-01-10
Accepted
2024-01-10 07:05:18
Documents
56
Period of Report
2024-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-20240110.htm   iXBRL 8-K 40774
2 EX-99.1 eypt-ex99_1.htm EX-99.1 40150
3 EX-99.2 eypt-ex99_2.htm EX-99.2 26640
4 GRAPHIC img97631278_0.jpg GRAPHIC 5406
5 GRAPHIC eypt-ex99_1s1.jpg GRAPHIC 242897
6 GRAPHIC eypt-ex99_1s2.jpg GRAPHIC 834658
7 GRAPHIC eypt-ex99_1s3.jpg GRAPHIC 530483
8 GRAPHIC eypt-ex99_1s4.jpg GRAPHIC 429695
9 GRAPHIC eypt-ex99_1s5.jpg GRAPHIC 347007
10 GRAPHIC eypt-ex99_1s6.jpg GRAPHIC 484913
11 GRAPHIC eypt-ex99_1s7.jpg GRAPHIC 423333
12 GRAPHIC eypt-ex99_1s8.jpg GRAPHIC 217432
13 GRAPHIC eypt-ex99_1s9.jpg GRAPHIC 509662
14 GRAPHIC eypt-ex99_1s10.jpg GRAPHIC 339179
15 GRAPHIC eypt-ex99_1s11.jpg GRAPHIC 381000
16 GRAPHIC eypt-ex99_1s12.jpg GRAPHIC 395040
17 GRAPHIC eypt-ex99_1s13.jpg GRAPHIC 410462
18 GRAPHIC eypt-ex99_1s14.jpg GRAPHIC 379562
19 GRAPHIC eypt-ex99_1s15.jpg GRAPHIC 402829
20 GRAPHIC eypt-ex99_1s16.jpg GRAPHIC 471450
21 GRAPHIC eypt-ex99_1s17.jpg GRAPHIC 439523
22 GRAPHIC eypt-ex99_1s18.jpg GRAPHIC 397997
23 GRAPHIC eypt-ex99_1s19.jpg GRAPHIC 329548
24 GRAPHIC eypt-ex99_1s20.jpg GRAPHIC 316435
25 GRAPHIC eypt-ex99_1s21.jpg GRAPHIC 293904
26 GRAPHIC eypt-ex99_1s22.jpg GRAPHIC 295195
27 GRAPHIC eypt-ex99_1s23.jpg GRAPHIC 347342
28 GRAPHIC eypt-ex99_1s24.jpg GRAPHIC 362781
29 GRAPHIC eypt-ex99_1s25.jpg GRAPHIC 363559
30 GRAPHIC eypt-ex99_1s26.jpg GRAPHIC 225414
31 GRAPHIC eypt-ex99_1s27.jpg GRAPHIC 376036
32 GRAPHIC eypt-ex99_1s28.jpg GRAPHIC 377992
33 GRAPHIC eypt-ex99_1s29.jpg GRAPHIC 467190
34 GRAPHIC eypt-ex99_1s30.jpg GRAPHIC 213544
35 GRAPHIC eypt-ex99_1s31.jpg GRAPHIC 498507
36 GRAPHIC eypt-ex99_1s32.jpg GRAPHIC 437429
37 GRAPHIC eypt-ex99_1s33.jpg GRAPHIC 215676
38 GRAPHIC eypt-ex99_1s34.jpg GRAPHIC 446007
39 GRAPHIC eypt-ex99_1s35.jpg GRAPHIC 312869
40 GRAPHIC eypt-ex99_1s36.jpg GRAPHIC 210140
41 GRAPHIC eypt-ex99_1s37.jpg GRAPHIC 493732
42 GRAPHIC eypt-ex99_1s38.jpg GRAPHIC 336777
43 GRAPHIC eypt-ex99_1s39.jpg GRAPHIC 215323
44 GRAPHIC eypt-ex99_1s40.jpg GRAPHIC 514057
45 GRAPHIC eypt-ex99_1s41.jpg GRAPHIC 347120
46 GRAPHIC eypt-ex99_1s42.jpg GRAPHIC 392210
47 GRAPHIC eypt-ex99_1s43.jpg GRAPHIC 238181
  Complete submission text file 0000950170-24-003512.txt   22642247

Data Files

Seq Description Document Type Size
48 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eypt-20240110.xsd EX-101.SCH 23897
50 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20240110_htm.xml XML 4523
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 24524850
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)